» 2019-06-27

Sun Pharmaceutical Industries today announced that it had licensed two of its products — for psoriasis and for dry eye — to China Medical System Holdings Ltd or CMS. CMS […]

» 2019-01-22

Sun Pharmaceutical Industries today announced a list of concrete steps to address investor concerns about certain relationships that it has with a couple of entities and loans allegedly extended to […]

» 2018-11-26

Sun Pharmaceutical Industries said it agreed to acquire Pola Pharma Inc, a Japanese pharmaceutical company engaged in the research and development, manufacture, sale and distribution of branded and generic products […]

» 2018-11-26

Sun Pharma Advanced Research Company Ltd, the research focused unit of Sun Pharma, said a trial of its cancer formulation, Paclitaxel Injection, “met all the endpoints” of a bioequivalence study […]

» 2018-09-14

Sun Pharmaceutical Industries said it has got US Food and Drug Administration  approval for a new eye drug that will be used for lowering intraocular pressure or IOP  in patients with […]

» 2018-08-14

India’s biggest drug maker Sun Pharmaceutical Industries reported strong numbers for the first quarter of Apr-Jun this year, with rising sales lifting margins and profits. Overall sales rose 16% on […]

» 2018-07-25

Sun Pharmaceutical Industries  said it has launched the glucose regulating drug  metformin hydrochloride in the United States. The tablets in two strengths — 500 mg and 1000 mg —  have […]

» 2018-05-18

India-based Sun Pharmaceutical Industries said it has launched an authorized generic version for Daiichi Sankyo’s cholesterol drug Welchol in the US market. The drug, whose compound name is colesevelam hydrochloride, […]

» 2018-02-14

Sun Pharmaceuticals Ltd, India’s largest drugmaker, reported a 14% decline in its revenue for the December quarter, led by a 35% fall in revenue from the sales of dosages in […]

» 2017-12-27

Sun Pharmaceutical Industries Ltd said the US FDA has accepted a New Drug Application (NDA) for its OTX-101 dry eye drug. The application will now be processed for approval. Dry […]

» 2017-07-04

Sun Pharma said it has inked a long-term agreement with Samsung BioLogics under which the Korean company will manufacture Tildrakizumab, a potential treatment for plaque psoriasis, for the Indian company. […]

» 2017-06-27

Sun Pharma announced a tie-up with National Institute of Virology (NIV) under the Indian Council of Medical Research for testing various compounds for treating rapidly spreading viral infections — Zika, […]

» 2016-10-19

Pharma major Sun Pharma said it tied up with research organization International Centre for Genetic Engineering and Biotechnology to develop vaccines for dengue. The vaccine is targeted against all the […]

Sign up to get the latest Pharma-related news delivered via email:

Don't forget to click on the activation link we send to your email